Private Wealth Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Private Wealth Asset Management's REGN Position: Q2 2026 in Review
Private Wealth Asset Management held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 31 shares worth $19.3K. The position accounts for ﹤0.01% of the portfolio, ranked #573.
Private Wealth Asset Management first reported a position in REGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $24K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Private Wealth Asset Management held 31 shares of Regeneron Pharmaceuticals worth $19.3K as of Q2 2026.
- Private Wealth Asset Management left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
- Regeneron Pharmaceuticals made up ﹤0.01% of Private Wealth Asset Management's portfolio in Q2 2026, its #573 holding.
- Private Wealth Asset Management first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
- Private Wealth Asset Management's Regeneron Pharmaceuticals position peaked at $24K in Q1 2026.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Private Wealth Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.